| Literature DB >> 30891578 |
Tohru Kimura1, Kazuhiko Kotani2.
Abstract
BACKGROUND: The aims of this study were (a) to ascertain age-related changes in the reference values in hematological and serum biochemical examinations of beagles, and (b) to clarify the changes in these findings, including acute phase proteins and oxidative stress, throughout pregnancy and after parturition.Entities:
Keywords: beagles; hematology; parturition; pregnancy; reactive oxygen metabolites; serum biochemistry
Year: 2018 PMID: 30891578 PMCID: PMC6388069 DOI: 10.1002/ame2.12043
Source DB: PubMed Journal: Animal Model Exp Med ISSN: 2576-2095
Hematological profiles in beagles (means ± SD)
| Parameters | Units | Sex | Age | |||
|---|---|---|---|---|---|---|
| 6 M | 9 M | 12 M | 24‐60 M | |||
| WBC | ×109/L | Male | 9.67 ± 1.97 | 8.15 ± 1.02 | 9.26 ± 1.69 | 8.01 ± 1.81 |
| Female | 9.46 ± 1.39 | 9.23 ± 2.46 | 10.96 ± 2.18 | 7.79 ± 1.17 | ||
| RBC | ×1012/L | Male | 6.65 ± 0.53 | 6.70 ± 0.32 | 7.48 ± 0.60 | 8.09 ± 0.49 |
| Female | 6.88 ± 0.48 | 7.42 ± 0.50 | 7.43 ± 0.81 | 7.80 ± 0.62 | ||
| Hb | g/L | Male | 149 ± 9 | 152 ± 7 | 166 ± 13 | 179 ± 11 |
| Female | 155 ± 11 | 167 ± 12 | 168 ± 17 | 169 ± 20 | ||
| PCV ratio | Male | 0.45 ± 0.03 | 0.46 ± 0.02 | 0.50 ± 0.0 | 0.53 ± 0.03 | |
| Female | 0.47 ± 0.03 | 0.50 ± 0.04 | 0.50 ± 0.05 | 0.51 ± 0.05 | ||
| MCV | fL | Male | 67.7 ± 1.9 | 69.2 ± 2.4 | 68.9 ± 8.0 | 65.7 ± 3.0 |
| Female | 68.4 ± 1.9 | 68.0 ± 1.7 | 68.4 ± 2.1 | 65.5 ± 3.8 | ||
| MCH | pg | Male | 22.4 ± 0.6 | 22.2 ± 0.7 | 22.1 ± 0.7 | 22.1 ± 1.0 |
| Female | 22.7 ± 0.7 | 22.6 ± 0.4 | 22.6 ± 0.4 | 21.6 ± 1.6 | ||
| MCHC | g/L | Male | 331 ± 6 | 328 ± 4 | 331 ± 5 | 337 ± 4 |
| Female | 330 ± 5 | 331 ± 6 | 330 ± 5 | 329 ± 10 | ||
| RDW | fL | Male | 33.5 ± 1.5 | 34.5 ± 1.2 | 34.3 ± 1.1 | 35.3 ± 1.2 |
| Female | 34.1 ± 1.1 | 34.1 ± 1.5 | 35.1 ± 1.8 | 35.0 ± 1.8 | ||
| PLT | ×109/L | Male | 303 ± 102 | 297 ± 54 | 273 ± 71 | 261 ± 71 |
| Female | 316 ± 49 | 292 ± 72 | 335 ± 77 | 294 ± 57 | ||
| PDW | fL | Male | 14.3 ± 2.0 | 13.3 ± 2.0 | 12.9 ± 2.2 | 12.6 ± 1.6 |
| Female | 14.3 ± 1.7 | 12.4 ± 1.0 | 12.7 ± 2.0 | 13.0 ± 1.5 | ||
| MPV | fL | Male | 11.8 ± 1.0 | 11.2 ± 0.9 | 10.8 ± 0.9 | 10.7 ± 0.8 |
| Female | 11.8 ± 1.0 | 10.9 ± 0.5 | 10.9 ± 1.0 | 11.1 ± 0.8 | ||
Hb, hemoglobin concentration; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MPV, mean platelet volume; PCV, packed cell volume; PDW, platelet distribution width; PLT, platelet count; RBC, red blood cell count; RDW, red blood cell distribution width; WBC, white cell count.
**Significantly different from 6 months old (6 M) (P < 0.01).
Serum biochemical profiles in healthy beagles (means ± SD)
| Parameters | Units | Sex | Age | |||
|---|---|---|---|---|---|---|
| 6 M | 9 M | 12 M | 24‐60 M | |||
| TP | g/L | Male | 54.6 ± 2.0 | 60.7 ± 3.6 | 65.1 ± 4.3 | 71.5 ± 4.0 |
| Female | 54.7 ± 2.8 | 58.9 ± 3.3 | 64.8 ± 4.5 | 65.1 ± 3.6 | ||
| Alb | g/L | Male | 32.7 ± 1.2 | 33.1 ± 1.6 | 33.3 ± 1.6 | 32.9 ± 2.0 |
| Female | 33.7 ± 1.7 | 34.9 ± 2.3 | 34.6 ± 2.3 | 34.7 ± 1.8 | ||
| A/G ratio | Male | 1.50 ± 0.11 | 1.21 ± 0.18 | 1.07 ± 0.16 | 0.87 ± 0.15 | |
| Female | 1.61 ± 0.15 | 1.48 ± 0.22 | 1.2 ± 0.28 | 1.17 ± 0.22 | ||
| T‐Bil | μmol/L | Male | 0.55 ± 0.20 | 0.76 ± 0.29 | 0.68 ± 0.25 | 0.82 ± 0.29 |
| Female | 0.60 ± 0.24 | 0.98 ± 0.21 | 1.11 ± 0.37 | 0.78 ± 0.24 | ||
| BUN | mmol/L | Male | 4.4 ± 1.1 | 5.0 ± 0.7 | 5.3 ± 0.7 | 5.1 ± 0.9 |
| Female | 4.4 ± 0.7 | 5.0 ± 0.7 | 5.5 ± 1.0 | 5.0 ± 0.8 | ||
| UA | μmol/L | Male | 13.9 ± 2.9 | 16.3 ± 2.7 | 20.6 ± 4.4 | 20.6 ± 3.1 |
| Female | 14.5 ± 2.7 | 17.5 ± 1.5 | 20.2 ± 3.0 | 15.5 ± 3.8 | ||
| Cre | μmol/L | Male | 49.8 ± 5.5 | 54.9 ± 5.8 | 58.5 ± 7.8 | 57.9 ± 6.8 |
| Female | 48.6 ± 7.2 | 56.6 ± 6.2 | 55.7 ± 5.9 | 54.6 ± 9.1 | ||
| Glu | mmol/L | Male | 5.27 ± 0.27 | 5.11 ± 0.22 | 4.91 ± 0.34 | 4.82 ± 0.25 |
| Female | 5.62 ± 0.29 | 5.19 ± 0.20 | 4.69 ± 0.28 | 4.94 ± 0.28 | ||
| TG | mmol/L | Male | 0.31 ± 0.07 | 0.30 ± 0.12 | 0.21 ± 0.07 | 0.25 ± 0.07 |
| Female | 0.30 ± 0.09 | 0.25 ± 0.08 | 0.27 ± 0.10 | 0.34 ± 0.12 | ||
| T‐CHO | mmol/L | Male | 4.40 ± 0.66 | 4.53 ± 0.78 | 3.70 ± 0.69 | 3.27 ± 0.75 |
| Female | 4.20 ± 0.45 | 3.85 ± 0.75 | 4.26 ± 0.90 | 4.55 ± 1.06 | ||
| HDL‐CHO | mmol/L | Male | 3.22 ± 0.46 | 3.40 ± 0.58 | 2.92 ± 0.52 | 2.60 ± 0.54 |
| Female | 3.14 ± 0.29 | 3.00 ± 0.54 | 3.30 ± 0.63 | 3.43 ± 0.64 | ||
| F‐CHO | mmol/L | Male | 1.20 ± 0.18 | 1.19 ± 0.20 | 0.95 ± 0.17 | 0.84 ± 0.20 |
| Female | 1.14 ± 0.13 | 1.00 ± 0.20 | 1.06 ± 0.21 | 1.17 ± 0.26 | ||
| NEFA | mmol/L | Male | 0.66 ± 0.22 | 0.65 ± 0.20 | 0.70 ± 0.15 | 0.54 ± 0.19 |
| Female | 0.66 ± 0.12 | 0.65 ± 0.20 | 0.70 ± 0.15 | 0.54 ± 0.19 | ||
| PL | mmol/L | Male | 4.09 ± 1.13 | 4.32 ± 0.56 | 3.78 ± 0.52 | 3.38 ± 0.61 |
| Female | 4.18 ± 0.39 | 3.86 ± 0.64 | 4.17 ± 0.66 | 4.37 ± 0.76 | ||
| AST | U/L | Male | 44.1 ± 25.4 | 30.1 ± 4.3 | 34.5 ± 7.6 | 40.1 ± 7.9 |
| Female | 35.1 ± 3.7 | 32.9 ± 3.3 | 36.4 ± 5.8 | 28.2 ± 1.9 | ||
| ALT | U/L | Male | 40.0 ± 10.4 | 36.4 ± 9.0 | 41.1 ± 11.4 | 64.9 ± 64.0 |
| Female | 42.1 ± 9.8 | 38.3 ± 8.9 | 35.4 ± 7.0 | 35.5 ± 11.3 | ||
| ALP | U/L | Male | 490.7 ± 111.1 | 301.3 ± 76.1 | 201.5 ± 53.2 | 188.2 ± 100.8 |
| Female | 464.9 ± 84.3 | 285.3 ± 42.9 | 221.5 ± 43.2 | 84.1 ± 103.6 | ||
| GGT | U/L | Male | 4.8 ± 0.9 | 4.3 ± 1.0 | 4.3 ± 1.0 | 6.1 ± 1.9 |
| Female | 4.5 ± 0.6 | 4.4 ± 0.6 | 4.2 ± 0.9 | 4.9 ± 1.4 | ||
| LDH | U/L | Male | 97.9 ± 33.4 | 122.4 ± 58.0 | 111.5 ± 41.5 | 113.8 ± 70.3 |
| Female | 80.5 ± 19.5 | 102.8 ± 28.9 | 136.7 ± 72.7 | 114.5 ± 96.4 | ||
| ChE | U/L | Male | 9.1 ± 1.7 | 8.9 ± 1.9 | 8.7 ± 3.0 | 8.5 ± 1.9 |
| Female | 9.9 ± 1.7 | 7.6 ± 1.5 | 9.3 ± 2.1 | 8.5 ± 3.0 | ||
| LAP | U/L | Male | 59.7 ± 10.9 | 49.6 ± 9.6 | 50.3 ± 11.5 | 39.7 ± 10.7 |
| Female | 59.3 ± 11.2 | 48.7 ± 11.4 | 52.1 ± 14.3 | 43.7 ± 24.6 | ||
| AMY | U/L | Male | 807.1 ± 158.5 | 879.5 ± 228.2 | 1024.5 ± 208.8 | 943.4 ± 230.5 |
| Female | 764.0 ± 148.1 | 776.8 ± 141.9 | 826.5 ± 162.1 | 790.7 ± 353.3 | ||
| CK | U/L | Male | 567.1 ± 733.8 | 208.7 ± 54.2 | 173.3 ± 84.0 | 171.3 ± 68.9 |
| Female | 331.9 ± 90.9 | 190.9 ± 45.1 | 185.5 ± 44.7 | 147.6 ± 91.5 | ||
| Na | mmol/L | Male | 149.5 ± 1.2 | 149.3 ± 0.8 | 150.3 ± 1.0 | 150.4 ± 1.2 |
| Female | 149.1 ± 0.8 | 149.7 ± 0.9 | 149.5 ± 1.7 | 148.7 ± 1.6 | ||
| K | mmol/L | Male | 4.9 ± 0.2 | 4.9 ± 0.2 | 4.7 ± 0.3 | 4.8 ± 0.2 |
| Female | 4.7 ± 0.2 | 4.5 ± 0.2 | 4.6 ± 0.3 | 4.5 ± 0.3 | ||
| Cl | mmol/L | Male | 111.5 ± 2.0 | 112.6 ± 1.5 | 113.7 ± 1.3 | 113.5 ± 1.4 |
| Female | 111.8 ± 0.9 | 113.0 ± 1.6 | 112.4 ± 1.2 | 111.8 ± 1.9 | ||
| Ca | mmol/L | Male | 2.84 ± 0.21 | 2.80 ± 0.06 | 2.69 ± 0.07 | 2.57 ± 0.08 |
| Female | 2.82 ± 0.08 | 2.75 ± 0.06 | 2.71 ± 0.09 | 2.59 ± 0.10 | ||
| IP | mmol/L | Male | 2.25 ± 0.14 | 1.84 ± 0.15 | 1.58 ± 0.12 | 1.31 ± 0.17 |
| Female | 2.24 ± 0.17 | 1.63 ± 0.16 | 1.57 ± 0.19 | 1.25 ± 0.17 | ||
| CRP | nmol/L | Male | 32.4 ± 29.6 | 34.0 ± 32.3 | 32.8 ± 35.0 | 24.2 ± 35.0 |
| Female | 11.9 ± 13.8 | 22.9 ± 21.2 | 33.7 ± 28.7 | 12.4 ± 22.3 | ||
| SAA | μg/mL | Male | 2.21 ± 1.74 | 2.17 ± 1.03 | 2.40 ± 0.84 | 2.73 ± 1.52 |
| Female | 1.91 ± 1.04 | 2.21 ± 1.31 | 4.93 ± 5.93 | 2.49 ± 2.36 | ||
| d‐ROM | U. CARR | Male | 107.2 ± 29.5 | 103.3 ± 21.1 | 103.2 ± 19.5 | 102.6 ± 17.1 |
| Female | 94.5 ± 19.4 | 101.7 ± 35.3 | 96.0 ± 13.8 | 89.5 ± 12.3 | ||
A/G albumin/globulin ratio; Alb, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMS, amylase; AST, asparate aminotransferase; BUN, blood urea nitrogen; ChE, cholinesterase; CK, creatine kinase; Cre, creatinine; CRP, C‐reactive proteins; d‐ROMs, reactive oxygen metabolites; F‐CHO, free cholesterol; GGT, γ‐glutamyl transpeptidase; Glu, glucose; HDL‐CHO, high density lipoprotein‐cholesterol; IP, inorganic phosphorus; LAP, leucine aminopeptidase; LDH, lactate dehydrogenase; Na, K, Cl, Ca, electrolytes; NEFA, non‐esterified fatty acids; PL, phospholipids; SAA, serum amyloid A; T‐Bil, total bilirubin; T‐CHO, total cholesterol; TG, triglycerides; TP, total protein; UA, urate.
*Significantly different from 6 months old (6 M) (P < 0.05).
**Significantly different from 6 M (P < 0.01).
Figure 1Hematological changes (means ± SD) during pregnancy in beagles. RBC, red blood cell count; Hb, hemoglobin concentration; PCV, packed cell volume; WBC, white cell count; PLT, platelet count. Marked changes in hematological parameters are found after 50 d of pregnancy. *Significantly different from Day 0 (P < 0.05). **Significantly different from Day 0 (P < 0.01)
Figure 2Serum biochemical changes (means ± SD) during pregnancy and after parturition of beagles. TP, total protein; Alb, albumin; A/G, albumin/globulin ratio; BUN, blood urea nitrogen; UA, urate; Cre, creatinine; Glu, glucose; TG, triglycerides; T‐CHO, total cholesterol; HDL‐CHO, high density lipoprotein‐cholesterol. Marked decreases in protein metabolism (Alb and A/G ratio) are noted during pregnancy. Significant increases in lipid metabolism (TG and T‐CHO) are observed in mid‐ and late stages of pregnancy. *Significantly different from Day 0 (P < 0.05). **Significantly different from Day 0 (P < 0.01). ▵, parturition
Figure 3Serum biochemical changes (means ± SD) during pregnancy and after parturition of beagles. F‐CHO, free cholesterol; NEFA, non‐esterified fatty acids; PL, phospholipids; ALP, alkaline phosphatase; GGT, γ‐glutamyl transpeptidase; LDH, lactate dehydrogenase; ChE: cholinesterase; CK, creatine kinase. Marked increases in lipid metabolism (F‐CHO and PL) are observed at 30‐50 d of pregnancy. Enzyme activities (ALP, LDH, ChE, and CK) are also changed. *Significantly different from Day 0 (P < 0.05) **Significantly different from Day 0 (P < 0.01). ▵, parturition
Figure 4Serum biochemical changes (means ± SD) during pregnancy and after parturition of beagles. CRP, C‐reactive proteins; SAA, serum amyloid A; d‐ROMs, reactive oxygen metabolites. Increased CRP, SAA, and d‐ROM levels are noted in mid‐pregnancy of beagles. *Significantly different from Day 0 (P < 0.05). **Significantly different from Day 0 (P < 0.01). ▵, parturition